Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs high-dose filgrastim for neutrophil recovery after cytarabine consolidation in AML
TCTR20201010001Recruiting
- Sponsor
- Siriraj Hospital
- Start
- Oct 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of filgrastim in acute myeloid leukemia (AML) (2 arms), sponsored by Siriraj Hospital. Primary endpoint: Time to neutrophil recovery. Started Oct 2020; status: recruiting.
02
Drugs
filgrastim
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on TCTR20201010001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201010001.